Ultrahuman has announced the U.S. launch of M2 Live, its latest metabolic health platform designed to give consumers deeper insight into how their bodies respond to food, exercise, sleep, and stress. By integrating glucose data from Abbott’s over-the-counter Lingo continuous glucose monitor (CGM), the company is making continuous glucose tracking more accessible for adults interested in improving their overall health and wellness.
The launch marks one of the first consumer platforms to support Lingo, Abbott’s prescription-free CGM for adults ages 18 and older who are not using insulin. With sensors available through subscriptions starting at $99 per month, Ultrahuman says M2 Live lowers the cost and complexity that have traditionally limited access to glucose monitoring.
Looking beyond glucose alone
Continuous glucose monitors have become increasingly popular outside of diabetes care, with many users relying on them to understand how meals, workouts, and daily habits affect their bodies. Ultrahuman’s approach goes a step further by combining glucose readings with data from its broader health ecosystem.
When paired with the Ultrahuman Ring and the company’s Blood Vision biomarker platform, M2 Live analyzes glucose alongside sleep quality, stress, activity, recovery, heart rate variability, and skin temperature. The company says this provides greater context for identifying what may be driving changes in metabolic health rather than simply reporting glucose values.
Powering those insights is Jade AI, Ultrahuman’s real-time health intelligence system that connects multiple health signals into personalized recommendations.
Features aimed at everyday health
M2 Live includes several tools intended to help users interpret glucose data in practical ways. A clinically validated Metabolic Score provides a daily rating from 0 to 100 that reflects glucose regulation. The platform also offers spike detection alerts, personalized Food Scores that rate how meals affect glucose levels, and Fueling Scores designed to help users understand glucose availability before and after exercise.
Another component is OGDb, which Ultrahuman describes as the world’s largest open glucose database, built from anonymized user data to show average glucose responses to different foods.
Rather than turning every meal into a pop quiz, the platform aims to make trends easier to spot over time.
Research-backed platform
Ultrahuman says its metabolic intelligence engine is built on five years of research, nearly 10 million logged meals, and collaborations with several academic and clinical institutions.
The company highlights a 2024 multi-site clinical study published in Nature that validated its Metabolic Score against established biomarkers of insulin resistance and glucose tolerance. It also points to a 2026 sleep and metabolism study conducted with Stanford’s Snyder Lab, Bangor University, and La Trobe University that analyzed more than 227,000 nights of sleep data from participants across 100 countries. An ongoing collaboration with the Mayo Clinic is examining metabolic changes in non-diabetic patients using GLP-1 medications.
Pricing and availability
Ultrahuman says M2 Live will launch in the U.S. through its website in the coming weeks. Individual Lingo biosensors are priced at $129 each, with subscription pricing starting at $99 per month. Each sensor can be worn for up to 14 days.
More information about Ultrahuman M2 Live is available on the official website at https://www.ultrahuman.com. Safety information for Abbott’s Lingo continuous glucose monitor can be found at https://www.hellolingo.com/safety-information.
